13982 Federal Register / Vol. 66, No. 46 / Thursday, March 8, 2001 / Notices

1 15 U.S.C. 78l(d).

the ADAMS Public Library component

on the NRC Web site, http://

www.nrc.gov (the Electronic Reading

Room).

Dated at Rockville, Maryland, this 31st day

of January, 2001.

For the Nuclear Regulatory Commission.

Ledyard B. Marsh,

Chief, Events Assessment, Generic

Communications and Non-Power Reactors

Branch, Division of Regulatory Improvement

Programs, Office of Nuclear Reactor

Regulation.

[FR Doc. 01–5744 Filed 3–7–01; 8:45 am]

BILLING CODE 7590–01–P

NUCLEAR REGULATORY

COMMISSION

Advisory Committee on Reactor

Safeguards; Meeting of the

Subcommittee on Plant License

Renewal; Notice of Meeting

The ACRS Subcommittee on Plant

License Renewal will hold a meeting on

March 27, 2001, Room T–2B3, 11545

Rockville Pike, Rockville, Maryland.

The entire meeting will be open to

public attendance.

The agenda for the subject meeting

shall be as follows:

Tuesday, March 27, 2001—8:30 a.m.

until the conclusion of business.

The Subcommittee will review

selected boiling water reactor Vessel

and Internals Project (BWRVIP) reports

applicable to Hatch license renewal and

the proposed final revisions of license

renewal regulatory guidance documents

(Generic Aging Lessons Learned (GALL)

report, Standard Review Plan,

Regulatory Guide, and NEI 95–10,

Industry Guideline for Implementing

the Requirements of 10 CFR Part 54—

The License Renewal Rule). The

purpose of this meeting is to gather

information, analyze relevant issues and

facts, and to formulate proposed

positions and actions, as appropriate,

for deliberation by the full Committee.

Oral statements may be presented by

members of the public with the

concurrence of the Subcommittee

Chairman; written statements will be

accepted and made available to the

Committee. Electronic recordings will

be permitted only during those portions

of the meeting that are open to the

public, and questions may be asked only

by members of the Subcommittee, its

consultants, and staff. Persons desiring

to make oral statements should notify

the cognizant ACRS staff engineer

named below five days prior to the

meeting, if possible, so that appropriate

arrangements can be made.

During the initial portion of the

meeting, the Subcommittee, along with

any of its consultants who may be

present, may exchange preliminary

views regarding matters to be

considered during the balance of the

meeting.

The Subcommittee will then hear

presentations by and hold discussions

with representatives of the NRC staff,

BWRVIP, and other interested persons

regarding this review.

Further information regarding topics

to be discussed, whether the meeting

has been canceled or rescheduled, and

the Chairman’s ruling on requests for

the opportunity to present oral

statements and the time allotted

therefor, can be obtained by contacting

the cognizant ACRS staff engineer, Mr.

Sam Duraiswamy (telephone 301/415–

7364) between 7:30 a.m. and 4:15 p.m.

(EST). Persons planning to attend this

meeting are urged to contact the above

named individual one or two working

days prior to the meeting to be advised

of any potential changes to the agenda,

etc., that may have occurred.

Dated: March 1, 2001.

James E. Lyons,

Associate Director for Technical Support,

ACRS/ACNW.

[FR Doc. 01–5752 Filed 3–7–01; 8:45 am]

BILLING CODE 7590–01–P

NUCLEAR REGULATORY

COMMISSION

Advisory Committee on Reactor

Safeguards

Meeting of the Subcommittee on Plant

License Renewal; Notice of Meeting

The ACRS Subcommittee on Plant

License Renewal will hold a meeting on

March 28, 2001, Room T–2B3, 11545

Rockville Pike, Rockville, Maryland.

The entire meeting will be open to

public attendance.

The agenda for the subject meeting

shall be as follows:

Wednesday, March 28, 2001—8:30 a.m.

until the conclusion of business

The Subcommittee will discuss the

draft Safety Evaluation Report for the

Southern Nuclear Operating Company,

Inc., license renewal application for

Hatch Units 1 and 2. The purpose of this

meeting is to gather information,

analyze relevant issues and facts, and to

formulate proposed positions and

actions, as appropriate, for deliberation

by the full Committee.

Oral statements may be presented by

members of the public with the

concurrence of the Subcommittee

Chairman; written statements will be

accepted and made available to the

Committee. Electronic recordings will

be permitted only during those portions

of the meeting that are open to the

public, and questions may be asked only

by members of the Subcommittee, its

consultants, and staff. Persons desiring

to make oral statements should notify

the cognizant ACRS staff engineer

named below five days prior to the

meeting, if possible, so that appropriate

arrangements can be made.

During the initial portion of the

meeting, the Subcommittee, along with

any of its consultants who may be

present, may exchange preliminary

views regarding matters to be

considered during the balance of the

meeting.

The Subcommittee will then hear

presentations by and hold discussions

with representatives of the NRC staff,

Southern Nuclear Operating Company,

Inc., and other interested persons

regarding this review.

Further information regarding topics

to be discussed, whether the meeting

has been canceled or rescheduled, and

the Chairman’s ruling on requests for

the opportunity to present oral

statements and the time allotted

therefor, can be obtained by contacting

the cognizant ACRS staff engineer, Mr.

Sam Duraiswamy (telephone 301/415–

7364) between 7:30 a.m. and 4:15 p.m.

(EST). Persons planning to attend this

meeting are urged to contact the above

named individual one or two working

days prior to the meeting to be advised

of any potential changes to the agenda,

etc., that may have occurred.

Dated: March 1, 2001.

James E. Lyons,

Associate Director for Technical Support,

ACRS/ACNW.

[FR Doc. 01–5753 Filed 3–7–01; 8:45 am]

BILLING CODE 7590–01–P

SECURITIES AND EXCHANGE

COMMISSION

Issuer Delisting; Notice of Application

to Withdraw from Listing and

Registration; (Integrated Orthopaedics,

Inc., Common Stock, $.001 Par Value)

File No. 1–10677

March 2, 2001.

Integrated Orthopaedics, Inc., a Texas

corporation (‘‘Issuer’’), has filed an

application with the Securities and

Exchange Commission (‘‘Commission’’),

pursuant to section 12(d) of the

Securities Exchange Act of 1934

(‘‘Act’’) 1 and Rule 12d2–2(d)

Federal Register / Vol. 66, No. 46 / Thursday, March 8, 2001 / Notices 13983

2 17 CFR 240.12d2–2(d).

3 15 U.S.C. 78l(b).

4 17 CFR 200.30–3(a)(1).

thereunder,2 to withdraw its Common

Stock, $.001 par value (‘‘Security’’),

from listing and registration on the

American Stock Exchange (‘‘Amex’’).

Amex listing guidelines require that,

when a listed company is acquired by

an unlisted company, even though the

listed company is the nominal survivor,

the Amex will apply its original listing

criteria in evaluating the eligibility of

the surviving company for listing.

Representatives of the Amex have

advised the Issuer that, upon

completion of the Issuer’s expected

merger with PowerBrief, Inc., its

Security will no longer be eligible to be

listed on the Amex because the resultant

combined company will not meet the

Amex’s original listing criteria. As a

result, the Issuer has determined to

voluntarily withdraw its Security from

listing and registration on the Amex at

this time. The Issuer has indicated that

it will pursue the possibility of having

the Security quoted in the unlisted overthe-counter market once it has ceased to

trade on the Amex.

The Issuer has stated in its

application that it has complied with

the rules of the Amex governing the

withdrawal of its Security and that the

application relates solely to the

withdrawal of the Security from listing

on the Amex and registration under

Section 12(b) of the Act.3

Any interested person may, on or

before March 23, 2001, submit by letter

to the Secretary of the Securities and

Exchange Commission, 450 Fifth Street,

N.W., Washington, D.C. 20549–0609,

facts bearing upon whether the

application has been made in

accordance with the rules of the Amex

and what terms, if any, should be

imposed by the Commission for the

protection of investors. The

Commission, based on the information

submitted to it, will issue an order

granting the application after the date

mentioned above, unless the

Commission determines to order a

hearing on the matter.

For the Commission, by the Division of

Market Regulation, pursuant to delegated

authority.4

Jonathan G. Katz,

Secretary.

[FR Doc. 01–5690 Filed 3–7–01; 8:45 am]

BILLING CODE 8010–01–M

SECURITIES AND EXCHANGE

COMMISSION

[Investment Company Act Release No.

24884; 812–12338]

Barr Rosenberg Series Trust; AXA

Rosenberg Investment Management

LLC, and AXA Rosenberg Group LLC;

Notice of Application

March 2, 2001.

AGENCY: Securities and Exchange

Commission (‘‘Commission’’).

ACTION: Notice of an application under

section 17(b) of the Investment

Company Act of 1940 (the ‘‘Act’’) for an

exemption from section 17(a) of the Act.

Summary of Application: Applicants

request an order to permit a series of a

registered open-end management

investment company to acquire all of

the assets, subject to the liabilities, of

another series of the investment

company. Because of certain affiliations,

applicants may not rely on rule 17a–8

under the Act.

Applicants G: Barr Rosenberg Series

Trust (the ‘‘Trust’’), AXA Rosenberg

Investment Management LLC (the

‘‘Adviser’’), and AXA Rosenberg Group

LLC (‘‘AXA Rosenberg Group’’).

Filing Dates: The application was

filed on November 27, 2000, and was

amended on March 2, 2001.

Hearing or Notification of Hearing: An

order granting the application will be

issued unless the Commission orders a

hearing. Interested persons may request

a hearing by writing to the

Commission’s Secretary and serving

applicants with a copy of the request,

personally or by mail. Hearing requests

should be received by the Commission

by 5:30 p.m. on March 23, 2001 and

should be accompanied by proof of

service on applicants, in the form of an

affidavit, or, for lawyers, a certificate of

service. Hearing requests should state

the nature of the writer’s interest, the

reason for the request, and the issues

contested. Persons who wish to be

notified of a hearing may request

notification by writing to the

Commission’s Secretary.

ADDRESSES: Secretary, Commission, 450

Fifth Street, NW., Washington, DC

20549–0609; Applicants: c/o J.B.

Kittredge, Jr., Esq., Ropes & Gray, One

International Place, Boston,

Massachusetts 02110–2624, Kenneth

Reid and Sara Ronan, AXA Rosenberg

Investment Management LLC, Four

Orinda Way, Building E, Orinda,

California 94563.

FOR FURTHER INFORMATION CONTACT:

Deepak T. Pai, Senior Counsel, at (202)

942–0574 or Janet M. Grossnickle,

Branch Chief, at (202) 942–0564,

(Division of Investment Management,

Office of Investment Company

Regulation).

SUPPLEMENTARY INFORMATION: The

following is a summary of the

application. The complete application

may be obtained for a fee at the

Commission’s Public Reference Branch,

450 Fifth Street, NW., Washington, DC

20549–0102 (telephone (202) 942–8090).

Applicants’ Representations

1. The Trust, a Massachusetts

business trust, is registered under the

Act as an open-end management

investment company and is currently

comprised of ten series, including the

AXA Rosenberg Japan Fund (the ‘‘Japan

Fund’’) and the AXA Rosenberg

International Equity Fund (the

‘‘International Fund’’ and together with

the Japan Fund, the ‘‘Funds’’).

2. The Adviser is the investment

adviser for the Funds, and is registered

as an investment adviser under the

Investment Advisers Act of 1940 (the

‘‘Advisers Act’’). The Adviser is owned

100% by AXA Rosenberg Group. AXA

Rosenberg Group is indirectly

controlled by AXA Group, a French

holding company for an international

group of insurance and related financial

services companies. AXA Group also

controls The Equitable Assurance

Society of the United States

(‘‘Equitable’’). AXA Rosenberg Group

owns for its own account approximately

82% of the outstanding voting securities

of the Japan Fund, and Equitable owns

for its own account approximately

100% of the outstanding voting

securities of the International Fund.

3. On December 4, 2000, the board of

directors of the Trust (the ‘‘Board’’),

including all of the directors who are

not ‘‘interested persons’’ as defined in

section 2(a)(19) of the Act

(‘‘Independent Directors’’), unanimously

approved an Agreement and Plan of

Reorganization (the ‘‘Plan’’). The Plan

provides that, on a date in the first

quarter of 2001 (the ‘‘Merger Date’’),

substantially all of the assets, subject to

the liabilities, of the Japan Fund will be

sold to the International Fund (the

‘‘Merger’’). The Plan provides that, as

payment for such assets, the

International Fund will issue to the

Japan Fund a number of shares of

designated classes which will be

calculated to equal in aggregate value

the net assets attributable to the shares

of the corresponding classes of the Japan

Fund acquired by the International

Fund. The shares issued by each class

of the International Fund will then be

distributed to the shareholders of the